KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme Group (CME) Operating Expenses: 2009-2025

Historic Operating Expenses for Cme Group (CME) over the last 17 years, with Sep 2025 value amounting to $565.0 million.

  • Cme Group's Operating Expenses rose 0.86% to $565.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 billion, marking a year-over-year increase of 1.99%. This contributed to the annual value of $2.2 billion for FY2024, which is 2.58% up from last year.
  • Cme Group's Operating Expenses amounted to $565.0 million in Q3 2025, which was up 0.41% from $562.7 million recorded in Q2 2025.
  • In the past 5 years, Cme Group's Operating Expenses ranged from a high of $578.2 million in Q4 2024 and a low of $487.5 million during Q1 2022.
  • Its 3-year average for Operating Expenses is $545.8 million, with a median of $534.3 million in 2025.
  • As far as peak fluctuations go, Cme Group's Operating Expenses decreased by 11.64% in 2021, and later increased by 8.29% in 2023.
  • Cme Group's Operating Expenses (Quarterly) stood at $515.6 million in 2021, then rose by 4.64% to $539.5 million in 2022, then grew by 6.78% to $576.1 million in 2023, then increased by 0.36% to $578.2 million in 2024, then rose by 0.86% to $565.0 million in 2025.
  • Its Operating Expenses stands at $565.0 million for Q3 2025, versus $562.7 million for Q2 2025 and $534.3 million for Q1 2025.